Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell renal cell carcinoma
Gerben Duns1, Eva van den Berg, Inge van Duivenbode
1Departments of Genetics and Pathology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
Abstract:
Sporadic clear cell renal cell carcinoma (cRCC) is genetically characterized by the recurrent loss of the short arm of chromosome 3, with a hotspot for copy number loss in the 3p21 region. We applied a method called "gene identification by nonsense-mediated mRNA decay inhibition" to a panel of 10 cRCC cell lines with 3p21 copy number loss to identify biallelic inactivated genes located at 3p21. This revealed inactivation of the histone methyltransferase gene SETD2, located on 3p21.31, as a common event in cRCC cells. SETD2 is nonredundantly responsible for trimethylation of the histone mark H3K36. Consistent with this function, we observed loss or a decrease of H3K36me3 in 7 out of the 10 cRCC cell lines. Identification of missense mutations in 2 out of 10 primary cRCC tumor samples added support to the involvement of loss of SETD2 function in the development of cRCC tumors.
Insights
Researchers identified the SETD2 gene as frequently inactivated in sporadic clear cell renal cell carcinoma (cRCC). Loss of SETD2 function impacts H3K36me3 levels, contributing to cRCC development.
Area of Science:
- Oncology
- Genetics
- Epigenetics
Background:
- Sporadic clear cell renal cell carcinoma (cRCC) frequently exhibits genetic alterations on chromosome 3p.
- A specific hotspot for copy number loss is located in the 3p21 region.
Purpose of the Study:
- To identify biallelically inactivated genes within the 3p21 region in cRCC cell lines.
- To investigate the role of SETD2 in the pathogenesis of cRCC.
Main Methods:
- Utilized gene identification by nonsense-mediated mRNA decay inhibition in 10 cRCC cell lines with 3p21 copy number loss.
- Analyzed histone H3 trimethylation at lysine 36 (H3K36me3) levels.
- Screened primary cRCC tumor samples for SETD2 mutations.
Main Results:
- Identified inactivation of the histone methyltransferase gene SETD2 (3p21.31) as a common event in cRCC cells.
- Observed loss or decreased H3K36me3 in 7 out of 10 cRCC cell lines, consistent with SETD2's function.
- Found missense mutations in SETD2 in 2 out of 10 primary cRCC tumors.
Conclusions:
- Loss of SETD2 function is implicated in the development of sporadic clear cell renal cell carcinoma.
- SETD2 inactivation and its impact on H3K36me3 represent a significant pathway in cRCC tumorigenesis.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
